Risk Factors in Stage 4 Neuroblastoma Patients Treated with Busulphan-Melphalan. Report from the European High Risk Neuroblastoma Hr-Nbl1/Siopen Trial

AuthID
P-00P-CNN
24
Author(s)
Poetschger, U
·
Elliot, M
·
Luksch, R
·
Castel, V
·
Yaniv, I
·
Papadakis, V
·
Laureys, G
·
Malis, J
·
Balwierz, W
·
[+4]·
Beck Popovic, M
·
Bician, P
·
Garami, M
·
Trahair, T
·
Ambros, P
·
Holmes, K
·
Schreier, G
·
Gaze, M
·
Pearson, A
·
Valteau Couanet, D
1
Group Author(s)
SIOP Europe Neuroblastoma Grp
Tipo de Documento
Abstract
Year published
2016
Publicado
in BONE MARROW TRANSPLANTATION, ISSN: 0268-3369
Volume: 51, Páginas: S46-S46 (1)
Conference
42Nd Annual Meeting of the European-Society-For-Blood-And-Marrow-Transplantation, Date: APR 03-06, 2016, Location: Valencia, SPAIN, Patrocinadores: European Soc Blood & Marrow Transplantat
Indexing
Publication Identifiers
Wos: WOS:000373357600073
Source Identifiers
ISSN: 0268-3369
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.
Name Order Nome   Name Order Nome   Name Order Nome
1 Ladenstein, R;   2 Poetschger, U;   3 Elliot, M;
4 Luksch, R;   5 Castel, V;   6 Yaniv, I;
7 Papadakis, V;   8 Laureys, G;   9 Malis, J;
10 Balwierz, W;   11 Ruud, E;   12 Kogner, P;
13 Schroeder, H;   14 de lacerda, AF;   15 Beck Popovic, M;
16 Bician, P;   17 Garami, M;   18 Trahair, T;
19 Ambros, P;   20 Holmes, K;   21 Schreier, G;
22 Gaze, M;   23 Pearson, A;   24 Valteau Couanet, D;